Recognizing and Addressing Risks of Shifting Epidemiology of Pneumococcal Disease in Adults 50+

Overview

Learning objectives/description:
• Discuss the ongoing burden and shifting epidemiology of pneumococcal disease in adults 50+
• Review the robust clinical trial program to help address invasive pneumococcal disease and pneumococcal pneumonia
• Highlight CDC recommendations for adult pneumococcal disease, including lowering vaccination age from 65 to 50"